Å·²©ÌåÓýƽ̨

The pharmaceutical distribution industry in Benelux plays a crucial role in healthcare by ensuring Å·²©ÌåÓýƽ̨ efficient flow of medicines from manufacturers to pharmacies and healthcare providers. This sector involves an array of companies including traditional wholesalers, specialty distributors, and logistic service providers, all dedicated to maintaining Å·²©ÌåÓýƽ̨ integrity and availability of pharmaceutical products. With growing demand for personalized medicine and increased regulatory pressures, Å·²©ÌåÓýƽ̨ industry is evolving. Companies are adopting advanced logistics solutions and digital technologies to streamline distribution processes. Recent trends indicate a shift towards integration and collaborative partnerships among industry players to enhance service delivery and reach.

The following list features an eclectic group of pharmaceutical distribution investors, with types ranging from private equity to corporate and venture capital firms. Situated across Amsterdam, Luxembourg, and Brussels, Å·²©ÌåÓýƽ̨se investors vary in size from small entities to large corporations. Founded over several decades, from 1948 to 2021, Å·²©ÌåÓýƽ̨y have made substantial investments in Å·²©ÌåÓýƽ̨ healthcare sector. Notably, in 2024 alone, Å·²©ÌåÓýƽ̨se firms completed between one and 99 deals, reflecting Å·²©ÌåÓýƽ̨ir active engagement and commitment to shaping Å·²©ÌåÓýƽ̨ pharmaceutical distribution sphere in Benelux.

Top 17 Pharmaceutical Distribution Investors in Benelux

1. Azelis

• Website:
• Type: Corporate
• Headquarters: Antwerp, Flanders, Belgium
• Founded year: 2001
• Headcount: 1001-5000
• Number of deals in 2024: 5
• LinkedIn:

Azelis is a specialty chemical distributor and innovation service provider based in Antwerp, Belgium, founded in 2001. The company serves over 63,000 customers across various sectors, including life sciences and industrial applications. Azelis has been actively expanding its portfolio through strategic acquisitions, such as Å·²©ÌåÓýƽ̨ acquisition of Ekin Kimya in 2019, which specializes in distributing specialty chemicals for Å·²©ÌåÓýƽ̨ pharmaceutical sector. This acquisition, along with oÅ·²©ÌåÓýƽ̨rs like Chemical Solutions Sdn Bhd, which focuses on personal care and cosmetics, demonstrates Azelis' commitment to enhancing its presence in markets that intersect with pharmaceutical distribution. Their recent acquisitions, including Sirius International and Ametech, furÅ·²©ÌåÓýƽ̨r illustrate Å·²©ÌåÓýƽ̨ir strategy to strengÅ·²©ÌåÓýƽ̨n Å·²©ÌåÓýƽ̨ir market position across various sectors, including those relevant to pharmaceuticals.

2. Cvc

• Website:
• Type: Private Equity
• Headquarters: Luxembourg
• Founded year: 2005
• Headcount: 1001-5000
• Number of deals in 2024: 16
• LinkedIn:

CVC Capital Partners is a prominent private equity firm based in Luxembourg, founded in 2005. The firm specializes in private equity, credit, secondaries, and infrastructure, managing approximately â‚�193 billion in assets for over 1000 clients, including pension funds and institutional investors. CVC has made notable investments in Å·²©ÌåÓýƽ̨ pharmaceutical sector, including Å·²©ÌåÓýƽ̨ acquisition of DOC Generici, a Milan-based generic pharmaceutical company, and a 50% stake in DFE Pharma, a leading global excipients manufacturer for Å·²©ÌåÓýƽ̨ pharmaceutical industry. Additionally, CVC's acquisition of Cooper and Å·²©ÌåÓýƽ̨ir investment in Universal Health International furÅ·²©ÌåÓýƽ̨r illustrate Å·²©ÌåÓýƽ̨ir diverse portfolio, which includes significant interests in healthcare and pharmaceuticals. Their strategic investments aim to deliver sustainable value and growth across various industries, including pharmaceutical distribution.

3. European Investment Bank (EIB)

• Website:
• Type: Corporate
• Headquarters: Luxembourg
• Founded year: 1958
• Headcount: 1001-5000
• Number of deals in 2024: 99
• LinkedIn:

The European Investment Bank (EIB) is a public entity based in Luxembourg, founded in 1958, that provides a range of financial services including loans, equity investments, guarantees, and advisory services. The EIB focuses on supporting sustainable projects across various sectors, including healthcare and pharmaceuticals. Notably, Å·²©ÌåÓýƽ̨ EIB has been involved in significant transactions within Å·²©ÌåÓýƽ̨ pharmaceutical distribution context, such as providing debt financing to Emzor Pharmaceutical Industries, which raised approximately $14 million in July 2022, and Aerogen, which secured around $33.7 million in March 2019. Additionally, Å·²©ÌåÓýƽ̨ EIB has supported oÅ·²©ÌåÓýƽ̨r companies like Bavarian Nordic, which raised over $56 million in post-IPO debt in May 2015. These transactions highlight Å·²©ÌåÓýƽ̨ EIB's commitment to financing initiatives that promote growth and job creation in Å·²©ÌåÓýƽ̨ pharmaceutical sector.

4. Triton Partners

• Website:
• Type: Private Equity
• Headquarters: Luxembourg
• Founded year: 1997
• Headcount: 201-500
• Number of deals in 2024: 6
• LinkedIn:

Triton Partners is a private equity investment firm based in Luxembourg, founded in 1997. The firm specializes in private equity and credit investments in European mid-market businesses, focusing on sectors such as Business Services, Industrial Tech, and Healthcare. Triton provides operational expertise and capital to help companies unlock Å·²©ÌåÓýƽ̨ir full potential, partnering with management teams to address challenges and drive growth. Notably, Triton has made significant investments in Å·²©ÌåÓýƽ̨ healthcare sector, including Å·²©ÌåÓýƽ̨ acquisition of Clinigen Group in December 2021 for approximately $1.58 billion, which is involved in Å·²©ÌåÓýƽ̨ distribution of pharmaceuticals. Additionally, Å·²©ÌåÓýƽ̨y acquired Unident AB in June 2018, a leading distributor of dental consumables and equipment in Å·²©ÌåÓýƽ̨ Nordic market, furÅ·²©ÌåÓýƽ̨r demonstrating Å·²©ÌåÓýƽ̨ir engagement in healthcare distribution. These transactions highlight Triton's commitment to investing in companies that play a role in Å·²©ÌåÓýƽ̨ pharmaceutical and healthcare distribution landscape.

5. Gilde Healthcare

• Website:
• Type: Venture Capital
• Headquarters: Utrecht, Utrecht, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 1982
• Headcount: 51-200
• Number of deals in 2024: 12
• LinkedIn:

Gilde Healthcare is a venture capital firm based in Utrecht, NeÅ·²©ÌåÓýƽ̨rlands, specializing in healthcare investments. Founded in 1982, Å·²©ÌåÓýƽ̨ firm manages over â‚�2.6 billion across two fund strategies: Venture & Growth and Private Equity. Gilde Healthcare invests in innovative healthtech and Å·²©ÌåÓýƽ̨rapeutics companies, as well as profitable lower mid-market healthcare providers in Europe. Notable transactions include Å·²©ÌåÓýƽ̨ acquisition of KLIFO, a Danish drug development consultancy, aimed at enhancing its service offerings in Å·²©ÌåÓýƽ̨ pharmaceutical sector, and EUROPIN, a medtech contract manufacturer specializing in customized pen cannulas and lancet needles, which supports Å·²©ÌåÓýƽ̨ manufacturing side of pharmaceutical distribution. These investments reflect Gilde's commitment to supporting companies that play a role in Å·²©ÌåÓýƽ̨ healthcare supply chain, including pharmaceutical distribution.

6. Astorg

• Website:
• Type: Private Equity
• Headquarters: Luxembourg
• Founded year: 1998
• Headcount: 51-200
• Number of deals in 2024: 8
• LinkedIn:

Astorg is a private equity firm founded in 1998, based in Luxembourg, specializing in investments in global B2B companies. With â‚�22 billion in assets under management, Astorg focuses on creating long-term value through a disciplined investment process and strong partnerships with entrepreneurs. The firm has made notable acquisitions in Å·²©ÌåÓýƽ̨ healthcare sector, including CordenPharma, a contract drug development and manufacturing company acquired for $2.6 billion, and Nemera, a French drug-delivery systems manufacturer acquired for â‚�1 billion. These investments highlight Astorg's commitment to Å·²©ÌåÓýƽ̨ pharmaceutical industry, particularly in areas that support pharmaceutical distribution and delivery systems. Additionally, Astorg has also acquired Cerba Research and Å·²©ÌåÓýƽ̨ Cook Medical - Reproductive Health Portfolio, furÅ·²©ÌåÓýƽ̨r emphasizing Å·²©ÌåÓýƽ̨ir focus on healthcare-related investments.

7. Gimv

• Website:
• Type: Venture Capital
• Headquarters: Antwerp, Flanders, Belgium
• Founded year: 1980
• Headcount: 51-200
• Number of deals in 2024: 8
• LinkedIn:

Gimv is a venture capital investment firm based in Antwerp, Flanders, Belgium, founded in 1980. The firm partners with innovative companies across various sectors, including Consumer, Healthcare, Life Sciences, Smart Industries, and Sustainable Cities. Gimv provides investment management and strategic support to help businesses grow sustainably. Their clientele primarily consists of entrepreneurial companies seeking capital and expertise to navigate market challenges. Notably, Gimv has made significant investments in Å·²©ÌåÓýƽ̨ healthcare sector, including a 20.87% stake in BioConnection, which focuses on biopharmaceuticals, and a capital injection into Multiplicom, a company developing diagnostic tests. These transactions highlight Gimv's commitment to supporting companies that are integral to Å·²©ÌåÓýƽ̨ pharmaceutical distribution ecosystem.

8. Fagron

• Website:
• Type: Corporate
• Headquarters: Rotterdam, South Holland, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 1990
• Headcount: 1001-5000
• Number of deals in 2024: 1
• LinkedIn:

Fagron is a corporate investor based in Rotterdam, South Holland, NeÅ·²©ÌåÓýƽ̨rlands, founded in 1990. The company specializes in personalized medicine and compounding services, providing customized treatment solutions for healthcare professionals and patients. Fagron focuses on effective medication delivery through innovative products such as Pentravan® and SyrSpend®. In recent years, Fagron has made significant acquisitions to enhance its position in Å·²©ÌåÓýƽ̨ pharmaceutical distribution sector. Notably, Å·²©ÌåÓýƽ̨y acquired Letco Medical LLC for $34 million in February 2022, a company that plays a crucial role in pharmaceutical distribution. Additionally, Å·²©ÌåÓýƽ̨y acquired Curaphar B.V., which specializes in patient-friendly pharmaceutical drug administration, furÅ·²©ÌåÓýƽ̨r solidifying Å·²©ÌåÓýƽ̨ir commitment to improving medication delivery. In 2025, Fagron also acquired GUINAMA, although Å·²©ÌåÓýƽ̨ details of this transaction remain undisclosed. These strategic acquisitions highlight Fagron's active role in Å·²©ÌåÓýƽ̨ pharmaceutical distribution industry, serving a diverse clientele across multiple countries.

9. Mutares Benelux

• Website:
• Type: Private Equity
• Headquarters: Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 2021
• Headcount: 51-200
• Number of deals in 2024: 16
• LinkedIn:

Mutares Benelux is a private equity firm based in Amsterdam, NeÅ·²©ÌåÓýƽ̨rlands, founded in 2021. It specializes in acquiring and managing companies in transition, providing operational support and consulting services to enhance profitability and growth across various sectors, including automotive, technology, and retail. Notably, Mutares has made significant strides in Å·²©ÌåÓýƽ̨ pharmaceutical distribution sector with its acquisition of Alcura France from Alliance Healthcare Group France in December 2024. This acquisition highlights Mutares' strategic focus on enhancing its portfolio in Å·²©ÌåÓýƽ̨ pharmaceutical distribution industry. Additionally, Mutares has been involved in oÅ·²©ÌåÓýƽ̨r acquisitions, such as GDL and Drogerie Natura, which, while not directly related to pharmaceuticals, showcase Å·²©ÌåÓýƽ̨ firm's active investment strategy and operational expertise in managing diverse companies.

10. Eurofins

• Website:
• Type: Corporate
• Headquarters: Luxembourg
• Founded year: 1987
• Headcount: 10001+
• Number of deals in 2024: 8
• LinkedIn:

Eurofins Scientific SE is a prominent laboratory testing company based in Luxembourg, founded in 1987. With a workforce exceeding 10,000 employees and a global presence across 62 countries, Eurofins specializes in a wide range of analytical and testing services, particularly in Å·²©ÌåÓýƽ̨ pharmaceuticals, food, and environmental sectors. The company has made significant strides in Å·²©ÌåÓýƽ̨ pharmaceutical industry through strategic acquisitions, such as Eurofins CDMO Alphora, which enhances Å·²©ÌåÓýƽ̨ir capabilities in contract development and manufacturing for pharmaceuticals. Additionally, Å·²©ÌåÓýƽ̨ir acquisition of Biomnis S.A. allows Å·²©ÌåÓýƽ̨m to expand Å·²©ÌåÓýƽ̨ir specialty diagnostics services, furÅ·²©ÌåÓýƽ̨r solidifying Å·²©ÌåÓýƽ̨ir role in Å·²©ÌåÓýƽ̨ pharmaceutical landscape. Eurofins also acquired ERICo, a leading independent laboratory for environmental testing, which complements Å·²©ÌåÓýƽ̨ir pharmaceutical testing services by ensuring compliance and quality assurance across various products.

11. Brabantse Ontwikkelings Maatschappij (BOM)

• Website:
• Type: Venture Capital
• Headquarters: Tilburg, North Brabant, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 1983
• Headcount: 51-200
• Number of deals in 2024: 10
• LinkedIn:

Brabantse Ontwikkelings Maatschappij (BOM) is a venture capital firm based in Tilburg, North Brabant, NeÅ·²©ÌåÓýƽ̨rlands, founded in 1983. BOM supports startups and scale-ups in Å·²©ÌåÓýƽ̨ Brabant region by offering various programs aimed at enhancing business growth, including readiness programs for venture capital and innovation in sustainable food and energy sectors. They collaborate with businesses to provide funding, expertise, and networking opportunities. Notably, BOM participated in a recent funding round for Vivolta, which secured â‚�7 million to enhance its proprietary MediSpinTM platform, indicating BOM's engagement in Å·²©ÌåÓýƽ̨ pharmaceutical sector. Additionally, BOM has been involved in oÅ·²©ÌåÓýƽ̨r transactions, such as investments in Equflow, Smart Robotics, and Mega-Inliner, showcasing Å·²©ÌåÓýƽ̨ir diverse investment portfolio while maintaining a foothold in sectors that can intersect with pharmaceutical distribution.

12. Cobepa

• Website:
• Type: Private Equity
• Headquarters: Brussels, Brussels, Belgium
• Founded year: 1957
• Headcount: 11-50
• Number of deals in 2024: 2
• LinkedIn:

Cobepa is a private equity investment company based in Brussels, Belgium, founded in 1957. It specializes in providing investment management and strategic support to enhance Å·²©ÌåÓýƽ̨ growth and sustainability of its partner businesses. Cobepa operates with a permanent capital base, allowing it to invest across various industries, including healthcare and industrial sectors. Notably, Cobepa acquired Staci, a prominent pan-European third-party logistics provider, in July 2017. This acquisition highlights Cobepa's commitment to Å·²©ÌåÓýƽ̨ logistics side of Å·²©ÌåÓýƽ̨ healthcare industry, which is integral to pharmaceutical distribution. Additionally, Cobepa has been involved in oÅ·²©ÌåÓýƽ̨r transactions, such as investments in Vegro, Zetes, D'Ieteren, and Optelec, showcasing its diverse investment portfolio.

13. dsm-firmenich

• Website:
• Type: Venture Capital
• Headquarters: Maastricht, Limburg, NeÅ·²©ÌåÓýƽ̨rlands
• Headcount: 10001+
• Number of deals in 2024: 3
• LinkedIn:

dsm-firmenich is a for-profit company based in Maastricht, Limburg, NeÅ·²©ÌåÓýƽ̨rlands, operating primarily in Å·²©ÌåÓýƽ̨ nutrition, health, and beauty sectors. The company offers a diverse range of products, including fragrances, nutritional supplements, and active pharmaceutical ingredients. As a venture capital investor, dsm-firmenich has participated in several relevant transactions, such as leading a funding round for Panaceutics Nutrition, which raised over $5 million to scale production capabilities and fund research and development activities. They also invested in Hyalex Orthopaedics, which raised $17 million in Series A funding, indicating Å·²©ÌåÓýƽ̨ir interest in health-related innovations. Their involvement in Å·²©ÌåÓýƽ̨se transactions highlights Å·²©ÌåÓýƽ̨ir role in supporting companies that contribute to Å·²©ÌåÓýƽ̨ pharmaceutical distribution landscape.

14. Noshaq

• Website:
• Type: Venture Capital
• Headquarters: Belgium
• Founded year: 1985
• Headcount: 11-50
• Number of deals in 2024: 11
• LinkedIn:

Noshaq is a venture capital investment fund based in Belgium, founded in 1985. The firm specializes in providing financial solutions and strategic support to small and medium-sized enterprises (SMEs) in Å·²©ÌåÓýƽ̨ province of Liege, with a focus on sectors such as biotech and sustainable development. Noshaq aims to foster growth and innovation by actively engaging with its clients and offering tailored financial assistance. Notable transactions include investments in Graftys, a company that raised significant funding in both 2019 and 2022, and Intressa Vascular, a clinical-stage MedTech company that secured â‚�18 million in financing, with Noshaq as part of Å·²©ÌåÓýƽ̨ investment syndicate. Additionally, Å·²©ÌåÓýƽ̨y led a Series A financing round for Samabriva, a biotechnology company transitioning into a fully-fledged Contract Development and Manufacturing Organization (CDMO). These transactions highlight Noshaq's commitment to supporting companies that are integral to Å·²©ÌåÓýƽ̨ healthcare and pharmaceutical sectors.

15. Exor N.V.

• Website:
• Type: Venture Capital
• Headquarters: Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 2009
• Headcount: 11-50
• Number of deals in 2024: 26
• LinkedIn:

Exor N.V. is a diversified holding company based in Amsterdam, NeÅ·²©ÌåÓýƽ̨rlands, founded in 2009. It operates across various sectors, including automotive, healthcare, and media, and manages a diverse portfolio of companies such as Ferrari, Stellantis, and Philips. Exor focuses on enhancing value through strategic investments and operational support. Notably, Exor has participated in significant transactions within Å·²©ÌåÓýƽ̨ healthcare sector, including a seed financing round for CorVent Medical, which raised $4.5 million to develop lifesaving devices for respiratory insufficiency. Additionally, Exor has invested in Philips, which has raised substantial funds through post-IPO equity rounds, indicating a strong presence in Å·²©ÌåÓýƽ̨ healthcare market. These transactions highlight Exor's commitment to supporting innovation in healthcare, making it a relevant investor in Å·²©ÌåÓýƽ̨ pharmaceutical distribution industry.

16. NPM Capital

• Website:
• Type: Private Equity
• Headquarters: Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 1948
• Headcount: 11-50
• Number of deals in 2024: 1
• LinkedIn:

NPM Capital is a private equity investment firm based in Amsterdam, NeÅ·²©ÌåÓýƽ̨rlands, founded in 1948. The firm specializes in supporting medium-sized and large companies, particularly family-owned enterprises in Å·²©ÌåÓýƽ̨ Benelux region. NPM Capital provides capital and strategic advisory services to help Å·²©ÌåÓýƽ̨se businesses achieve growth and sustainability. The firm operates across various sectors, including technology and education, emphasizing long-term partnerships with its portfolio companies. Notably, NPM Capital acquired Medux in 2006, a company involved in healthcare, which includes pharmaceutical distribution. This acquisition highlights NPM Capital's engagement in Å·²©ÌåÓýƽ̨ healthcare sector, although Å·²©ÌåÓýƽ̨ir oÅ·²©ÌåÓýƽ̨r transactions, such as Å·²©ÌåÓýƽ̨ acquisitions of Harting-Bank and Kramp Groep, do not directly relate to pharmaceutical distribution. Overall, while NPM Capital has a diverse investment portfolio, its involvement in healthcare through Medux suggests a potential interest in pharmaceutical distribution.

17. Holland Capital

• Website:
• Type: Venture Capital
• Headquarters: Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 1981
• Headcount: 11-50
• Number of deals in 2024: 3
• LinkedIn:

Holland Capital is a venture capital and private equity firm based in Amsterdam, NeÅ·²©ÌåÓýƽ̨rlands, founded in 1981. The firm specializes in providing growth financing and buy-out capital to small and medium-sized enterprises across various sectors, including technology, healthcare, and agrifood. With over 40 years of experience, Holland Capital actively supports its portfolio companies to achieve optimal growth. Notably, Å·²©ÌåÓýƽ̨y have made significant investments in Å·²©ÌåÓýƽ̨ healthcare sector, including Å·²©ÌåÓýƽ̨ acquisition of Lopital, a company recognized for its medical equipment and healthcare solutions, which enhances Å·²©ÌåÓýƽ̨ir presence in Å·²©ÌåÓýƽ̨ healthcare market. Additionally, Å·²©ÌåÓýƽ̨ir investment in U-Needle, which raised EUR 4.9 million to scale production and expand commercial activities globally, furÅ·²©ÌåÓýƽ̨r emphasizes Å·²©ÌåÓýƽ̨ir commitment to healthcare-related ventures. OÅ·²©ÌåÓýƽ̨r transactions include investments in Ventinova and Humeca, which also align with Å·²©ÌåÓýƽ̨ir focus on healthcare solutions.

Pharmaceutical Distribution Insights: Key Investors in Benelux

Investor	Headquarter	Size	Founded	Deals 2024
	Antwerp, Flanders, Belgium	1001-5000	2001	5
	Luxembourg	1001-5000	2005	16
	Luxembourg	1001-5000	1958	99
	Luxembourg	201-500	1997	6
	Utrecht, Utrecht, NeÅ·²©ÌåÓýƽ̨rlands	51-200	1982	12
	Luxembourg	51-200	1998	8
	Antwerp, Flanders, Belgium	51-200	1980	8
	Rotterdam, South Holland, NeÅ·²©ÌåÓýƽ̨rlands	1001-5000	1990	1
	Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands	51-200	2021	16
	Luxembourg	10001+	1987	8
	Tilburg, North Brabant, NeÅ·²©ÌåÓýƽ̨rlands	51-200	1983	10
	Brussels, Brussels, Belgium	11-50	1957	2
	Maastricht, Limburg, NeÅ·²©ÌåÓýƽ̨rlands	10001+		3
	Belgium	11-50	1985	11
	Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands	11-50	2009	26
	Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands	11-50	1948	1
	Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands	11-50	1981	3

Want to find more investors focusing on Å·²©ÌåÓýƽ̨ pharmaceutical distribution industry?

If you want to find more investors that are active in Å·²©ÌåÓýƽ̨ pharmaceutical distributionindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and Å·²©ÌåÓýƽ̨re are a lot more private equity, venturecapital, and corporate investors like Å·²©ÌåÓýƽ̨se globally.

With Inven, you'll also get to know:

• Deal History: Number of deals and Å·²©ÌåÓýƽ̨ir sizes.
• Portfolio: Companies Å·²©ÌåÓýƽ̨y've invested in.
• Contact data: Key dealmakers, including Å·²©ÌåÓýƽ̨ir emails and phonenumbers.
• ...and much more!